The rise in metastatic prostate cancer incidence, predicted by opponents of the 2012 US move away from routine PSA screening…
Read more
Taking enzalutamide improves overall survival and progression-free survival in men with hormone-sensitive metastatic…
Read more
Men undergoing treatment for prostate cancer can expect different effects on their sexual function two years later according…
Read more
Complementary and alternative therapies may not be evidence-based treatment for prostate cancer, but many patients may think…
Read more
Men recently diagnosed with prostate cancer are likely to opt for treatments that strike a balance between survival and…
Read more
Prostate cancer survivors taking androgen deprivation therapy (ADT) are at a increased risk of developing chronic diseases,…
Read more
Nearly three-quarters of Australian men with low-risk prostate cancer are not being followed-up in line with best practice,…
Read more